Category: News

Tel-Aviv, Israel, July 28, 2026 (GLOBE NEWSWIRE) — Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, USA and Israel, announced today that its Luxembourg subsidiary, Ellomay Luxembourg Holdings S.à r.l., signed an agreement to acquire 100% of the share capital of a project company holding a ready-to-build 51.75 MW / 207 MWh (4-hour) battery energy storage system (“BESS”) located in northern Italy. This is Ellomay’s first battery storage project in Italy, marking Ellomay’s entry into the Italian electricity storage market.

Tel-Aviv, Israel, July 28, 2026 (GLOBE NEWSWIRE) — Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, USA and Israel, announced today that its Luxembourg subsidiary, Ellomay Luxembourg Holdings S.à r.l., signed an agreement to acquire 100% of the share capital of a project company holding a ready-to-build 51.75 MW / 207 MWh (4-hour) battery energy storage system (“BESS”) located in northern Italy. This is Ellomay’s first battery storage project in Italy, marking Ellomay’s entry into the Italian electricity storage market.

Expanded panel advances the understanding of immune system across translational and clinical research in cancer, cardiovascular and metabolic diseases, autoimmune diseases and aging | Highly sensitive multiplex measurement captures regulatory proteins, like checkpoint inhibitors, and low abundance targets that standard platforms routinely miss

Expanded panel advances the understanding of immune system across translational and clinical research in cancer, cardiovascular and metabolic diseases, autoimmune diseases and aging | Highly sensitive multiplex measurement captures regulatory proteins, like checkpoint inhibitors, and low abundance targets that standard platforms routinely miss

Irvine, CA, July 28, 2026 (GLOBE NEWSWIRE) — Urban Armor Gear (UAG), leading designer of rugged, lightweight mobile device cases, power and accessories, is excited to announce the launch of its all-new UAG //  DRYOUT® collection, a purpose-built line of carry solutions engineered to protect, carry, and rescue your essential tech. Technology goes everywhere with us, and so does water. From rain and snow to spills and sudden drops, moisture can quickly compromise a device. At UAG, preparation has always been the standard, and the UAG // DRYOUT® collection extends that mindset beyond prevention and into recovery, engineered to support your device after exposure happens.

Bowie, MD., July 28, 2026 (GLOBE NEWSWIRE) — Blink Charging Co. (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global owner, operator, and provider of electric vehicle (EV) charging equipment and services, will announce its second quarter results on Thursday, August 6, 2026, following the close of financial markets. The Company’s will host a conference call and webcast that day at 4:30 p.m. Eastern Time to discuss the Company’s results that ended on June 30, 2026.

Brand Protection PR™ support will help cancer survivor advocates raise awareness of fertility preservation after diagnosis

Brand Protection PR™ support will help cancer survivor advocates raise awareness of fertility preservation after diagnosis

Airtripmaker announces expanded business class flight booking options from the United States.

New research indicates attention on laboratory modernization. As the Association for Diagnostics and Laboratory Medicine 2026 Annual Scientific Meeting and Clinical Lab Expo kicks off, Siemens Healthineers will unveil innovations designed to optimize strategic impact.

New research indicates attention on laboratory modernization. As the Association for Diagnostics and Laboratory Medicine 2026 Annual Scientific Meeting and Clinical Lab Expo kicks off, Siemens Healthineers will unveil innovations designed to optimize strategic impact.

Unlike free apps that monetize user data, the subscription model ensures unalterable court records, secure messaging, and total privacy for co-parents.

Unlike free apps that monetize user data, the subscription model ensures unalterable court records, secure messaging, and total privacy for co-parents.

Hong Kong, July 28, 2026 (GLOBE NEWSWIRE) — Everbright Digital Holding Limited (NASDAQ: EDHL) (“Company” or “Everbright”), an integrated marketing solutions provider headquartered in Hong Kong, today announced the closing of its previously announced registered public offering conducted on a best-efforts basis (“Offering”).

面向涂料及高性能材料客户，提供更广泛的产品选择、更雄厚的配方技术实力以及更可靠的供应链保障

Breiteres Produktportfolio, umfassendere Formulierungskompetenz und höhere Versorgungssicherheit für Kunden aus den Bereichen Beschichtungen und Performance Materials

Cette opération offre un choix de produits élargi, une expertise accrue en formulation et une chaîne d’approvisionnement plus fiable pour les clients des secteurs des revêtements et des matériaux de performance

為塗料及性能材料客戶帶來更豐富產品選擇、更深入配方技術，以及更可靠供貨保障

תספק מבחר רחב יותר של מוצרים, מומחיות מעמיקה יותר בפורמולציות ואספקה אמינה יותר ללקוחות בתחומי הציפויים וחומרים בעלי ביצועים גבוהים

תספק מבחר רחב יותר של מוצרים, מומחיות מעמיקה יותר בפורמולציות ואספקה אמינה יותר ללקוחות בתחומי הציפויים וחומרים בעלי ביצועים גבוהים

WUPPERTAL, Germany, July 28, 2026 (GLOBE NEWSWIRE) — German venture holding company Dib Holding has expanded its portfolio of AI-driven ventures, which now spans digital health, workforce education, business productivity software, and real estate across Germany, the United Arab Emirates, and the Gulf area.

BEIJING, July 28, 2026 (GLOBE NEWSWIRE) — Cheer Holding, Inc. (NASDAQ: CHR) (“Cheer Holding” or the “Company”), a leading provider of advanced mobile internet infrastructure and platform services, today announced its financial results for the six months ended June 30, 2026.

The amylin analogs and combination therapies competitive landscape report delivers important insights into approved as well as ongoing research of 20+ pipeline amylin analogs and combination therapies, clinical strategies, upcoming therapeutics, and commercial analysis.

The amylin analogs and combination therapies competitive landscape report delivers important insights into approved as well as ongoing research of 20+ pipeline amylin analogs and combination therapies, clinical strategies, upcoming therapeutics, and commercial analysis.